🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Status
Recruiting
Location
Henan Cancer Hospital
Start Date
2026-06-16
Trial ID
NCT07629817
Study hypothesis: Simultaneous FMC-Alemtuzumab administration followed by A...
Status
Completed
Location
University Hospital Cologne
Start Date
2010-06
Trial ID
NCT01186640
Treatments Being Tested
This study is a prospective, open-label, multicenter study in previously un...
Status
Recruiting
Location
The Affiliated Hospital of Xuzhou Medical University
Start Date
2026-03-01
Trial ID
NCT07680933
Treatments Being Tested
This is a prospective biological study evaluating the persistence of COVID-...
Status
Active Not Recruiting
Location
Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico
Start Date
2024-05-07
Trial ID
NCT06070961
This is a prospective, observational, multicenter, cohort study with 400 ne...
Status
Recruiting
Location
No. 197 Ruijin 2nd Road, Huangpu District, Shanghai
Start Date
2025-01-01
Trial ID
NCT06779435
Treatments Being Tested
Effective systemic therapy such as nivolumab as an adjuvant therapy has bee...
Status
Recruiting
Location
National Taiwan University Hospital
Start Date
2025-07-23
Trial ID
NCT06764355
Treatments Being Tested
The purpose of the study is to test the efficacy and tolerability of a mult...
Status
Completed
Location
Elisa Jacobsen Pulczynski
Start Date
2007-05
Trial ID
NCT01458730
Treatments Being Tested
Esophageal cancer is one of the most common malignancies, and concurrent ch...
Status
Completed
Location
The First Affiliated Hospital of Nanjing Medical University
Start Date
2022-01-01
Trial ID
NCT07015489
Treatments Being Tested
To assess the efficacy and safety of camrelizumab combined with rituximab, ...
Status
Unknown
Location
Multiple Locations
Start Date
2022-06-01
Trial ID
NCT05093140
Treatments Being Tested
To evaluate the efficacy and safety of TQB3702 tablets combined with immuno...
Status
Recruiting
Location
Cancer Hospital Chinise Academy of Medical Sciences
Start Date
2024-11-06
Trial ID
NCT06566586
Treatments Being Tested